As MARK4 was so predominantly down‐regulated by miR‐515‐5p in breast cancer cells (Fig 2B and C), we questioned whether silencing MARK4 would mimic the effect of miR‐515‐5p on cell morphology and in cell migration assays. The gene discussed is MARK4; the disease is breast carcinoma.